Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02560805 · ClinicalTrials.gov registry record · Phase 2
Role of Sympathetic Overactivity and Angiotensin II in PTSD and CV
A Phase 2 study, sponsored by Emory University.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 134
- Enrollment target
NCT02560805 is a Phase 2 study that is actively recruiting participants, run by Emory University. The registered enrollment target is 134 participants.
The verdict
NCT02560805, a Phase 2 study, is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 134 participants
- Enrollment target
Study Summary
The purpose of this study is to find out why patients with post-traumatic stress disorder (PTSD) have an increased risk for heart disease and high blood pressure later in life. A second purpose is to find out what causes PTSD patients to have high adrenaline levels during stress. This study will also test if a medicine called losartan improves high adrenaline levels in patients with PTSD and if a certain gene that has to do with high blood pressure might be associated with high adrenaline levels.
Interventions
- PROCEDURE Microneurography
- BEHAVIORAL Combat virtual reality video clip
- PROCEDURE Handgrip Exercise
- PROCEDURE Cold Pressor Test (CPT)
- DRUG Sodium Nitroprusside (SNP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2015-10 |
| Est. Completion | 2027-03-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02560805
The ClinicalTrials.gov registry entry for NCT02560805 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 134 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Microneurography is the first listed.
NCT02560805 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02560805 about?
NCT02560805 is a clinical study titled "Role of Sympathetic Overactivity and Angiotensin II in PTSD and CV". The purpose of this study is to find out why patients with post-traumatic stress disorder (PTSD) have an increased risk for heart disease and high blood pressure later in life. A second purpose is to find out what causes PTSD patients to have high adrenaline levels during stress. This study will als...
What is the current status of trial NCT02560805?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 134 participants. The study started on 2015-10. Estimated completion is 2027-03-30.
What interventions are being tested in trial NCT02560805?
The interventions under investigation include: Microneurography (PROCEDURE), Combat virtual reality video clip (BEHAVIORAL), Handgrip Exercise (PROCEDURE), Cold Pressor Test (CPT) (PROCEDURE), Sodium Nitroprusside (SNP) (DRUG).
Who is sponsoring clinical trial NCT02560805?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.